Aldeyra Therapeutics Inc (NASDAQ:ALDX) price on Wednesday, July 02, rose 1.78% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.0.
A look at the stock’s price movement, the close in the last trading session was $3.93, moving within a range at $3.94 and $4.21. The beta value (5-Year monthly) was 0.682. Turning to its 52-week performance, $7.20 and $1.14 were the 52-week high and 52-week low respectively. Overall, ALDX moved 88.68% over the past month.
Aldeyra Therapeutics Inc’s market cap currently stands at around $239.58 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ALDX is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend ALDX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ALDX’s current price about 26.38% and 49.57% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 76.64, while 7-day volatility ratio is 8.39% and 8.86% in the 30-day chart. Further, Aldeyra Therapeutics Inc (ALDX) has a beta value of 0.73. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $10 and high of $12. Looking at the price targets, the low is -150.0% off current price level while to achieve the yearly target high, price needs to move -200.0%. Nonetheless, investors will most likely welcome a -175.0% jump to $11 which is the analysts’ median price.
If we refocus on Aldeyra Therapeutics Inc (NASDAQ:ALDX), historical trading data shows that trading volumes averaged 1.25 over the past 10 days and 1.84 million over the past 3 months. The company’s latest data on shares outstanding shows there are 60.05 million shares.
The 2.92% of Aldeyra Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 56.12% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.49 million on 2025-06-13, giving us a short ratio of 5.58. The data shows that as of 2025-06-13 short interest in Aldeyra Therapeutics Inc (ALDX) stood at 773.0 of shares outstanding, with shares short falling to 4.75 million registered in 2025-05-15. Current price change has pushed the stock 20.85% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ALDX stock continues to rise going into the next quarter.
